Rani Therapeutics Holdings Inc - Ordinary Shares Class A
RANI
Get informed when a big investor buys or sells
+ FollowMarket Cap$114.12M
Close$
$0.17
72.5% downside
Current Fair Value
72.5% downsideOvervalued by 72.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $114.12 Million |
|---|---|
| Enterprise Value | $117.92 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.45 |
| Beta | 0.71 |
| Outstanding Shares | 187,168,000 |
Return
| Return on Equity | -76.83% |
|---|---|
| Return on Assets | -49.54% |
| Return on Invested Capital | -65.65% |
Valuation & Multiples
| P/E Ratio | -2.25 |
|---|---|
| PEG | -21.56 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 69.04 |
| Enterprise Value to EBIT | -3.58 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.22 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.05
Average shareholder expectationRevenue Estimate
$925,000
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.05
Average shareholder expectationRevenue Estimate
$1.28 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.7839▲ 75.53% |
|---|---|
| Total Calls | 27,300▼ 98.34% |
| Total Puts | 21,400▼ 54.56% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 24.40%▲ 0.65% |
|---|---|
| Total Invested | $34.72M▲ 10.54% |
| Investors Holding | 70▼ 7.00% |
ESG Score
No data
About Rani Therapeutics Holdings Inc
2,021 employees